KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Enterprise Value (2016 - 2025)

Biogen (BIIB) has 17 years of Enterprise Value data on record, last reported at -$97.6 million in Q3 2025.

  • For Q3 2025, Enterprise Value rose 94.26% year-over-year to -$97.6 million; the TTM value through Jun 2025 reached -$2.8 billion, down 44.52%, while the annual FY2024 figure was -$2.4 billion, 126.21% down from the prior year.
  • Enterprise Value reached -$97.6 million in Q3 2025 per BIIB's latest filing, up from -$2.8 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$97.6 million in Q3 2025 and bottomed at -$6.1 billion in Q2 2023.
  • Average Enterprise Value over 5 years is -$3.0 billion, with a median of -$2.6 billion recorded in 2021.
  • The widest YoY moves for Enterprise Value: up 94.26% in 2025, down 141.84% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$3.7 billion in 2021, then plummeted by 31.11% to -$4.9 billion in 2022, then soared by 78.58% to -$1.0 billion in 2023, then tumbled by 126.21% to -$2.4 billion in 2024, then soared by 95.89% to -$97.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$97.6 million in Q3 2025, -$2.8 billion in Q2 2025, and -$2.6 billion in Q1 2025.